SCHEMBL4022463

SCHEMBL4022463

COC(=O)C(Cc1ccccc1)NCC(=O)OC(C)(C)C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGA4 P13612 2/20 0.58
ITGB7 P26010 2/20 0.58
KLK5 Q9Y337 1/20 0.54
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
ATM Q13315 1/20 0.51
MAPT P10636 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
ALDH1A1 P00352 3/20 0.50
THRB P10828 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
HSD17B10 Q99714 1/20 0.50
POLB P06746 2/20 0.49
CTSS P25774 2/20 0.48
LMNA P02545 2/20 0.48
CTSL P07711 1/20 0.48
CTSB P07858 1/20 0.48
CTSK P43235 1/20 0.48
MDM4 O15151 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6440329 1.00 ITGA4 (0.58) ITGA4ITGB7KLK5MEN1KMT2A
SCHEMBL4022466 1.00 ITGA4 (0.58) ITGA4ITGB7KLK5MEN1KMT2A
SCHEMBL6428127 0.93 ITGA4 (0.62) ITGA4ITGB7KLK5ATMMAPT
SCHEMBL7438704 0.90 YAP1 (0.57) ITGA4ITGB7MEN1KMT2AALDH1A1
SCHEMBL7438699 0.90 YAP1 (0.57) ITGA4ITGB7MEN1KMT2AALDH1A1
SCHEMBL6600210 0.90 ITGA4 (0.53) ITGA4ITGB7KLK5MEN1KMT2A
SCHEMBL7439390 0.90 ITGA4 (0.53) ITGA4ITGB7KLK5MEN1KMT2A
SCHEMBL7439396 0.90 ITGA4 (0.53) ITGA4ITGB7KLK5MEN1KMT2A
SCHEMBL2476918 0.89 ACE (0.54) ITGA4ITGB7ATMMAPTTDP1
SCHEMBL3026223 0.89 ACE (0.54) ITGA4ITGB7ATMMAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1689713-A4 BENZYLETHER AND BENZYLAMINO BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER S DISEASE MERCK & CO INC (US) 2009-02-18 EP disclosed
EP-1689713-A1 BENZYLETHER AND BENZYLAMINO BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER S DISEASE Merck & Co., Inc. (US) 2006-08-16 EP disclosed
WO-2005051914-A1 BENZYLETHER AND BENZYLAMINO BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE MERCK & CO., INC. (US) 2005-06-09 WO disclosed